ZA927306B - Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines - Google Patents

Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines

Info

Publication number
ZA927306B
ZA927306B ZA927306A ZA927306A ZA927306B ZA 927306 B ZA927306 B ZA 927306B ZA 927306 A ZA927306 A ZA 927306A ZA 927306 A ZA927306 A ZA 927306A ZA 927306 B ZA927306 B ZA 927306B
Authority
ZA
South Africa
Prior art keywords
pct
pyrazines
neuroleptic
pyrido
substituted perhydro
Prior art date
Application number
ZA927306A
Other languages
English (en)
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA927306B publication Critical patent/ZA927306B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
ZA927306A 1991-09-25 1992-09-24 Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines ZA927306B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25

Publications (1)

Publication Number Publication Date
ZA927306B true ZA927306B (en) 1994-03-24

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927306A ZA927306B (en) 1991-09-25 1992-09-24 Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines

Country Status (25)

Country Link
US (1) US5565453A (de)
EP (1) EP0607163B1 (de)
JP (1) JPH08827B2 (de)
CN (1) CN1071167A (de)
AT (1) ATE146178T1 (de)
AU (1) AU655071B2 (de)
BR (1) BR9206541A (de)
CA (1) CA2118936A1 (de)
CZ (1) CZ281775B6 (de)
DE (1) DE69215886T2 (de)
DK (1) DK0607163T3 (de)
ES (1) ES2096099T3 (de)
FI (1) FI941377A0 (de)
GR (1) GR3022483T3 (de)
HU (1) HUT71488A (de)
IL (1) IL103204A (de)
MX (1) MX9205385A (de)
MY (1) MY108303A (de)
NO (1) NO941084D0 (de)
NZ (1) NZ244473A (de)
PL (1) PL170889B1 (de)
PT (1) PT100891A (de)
TW (1) TW215090B (de)
WO (1) WO1993006101A1 (de)
ZA (1) ZA927306B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3287574B2 (ja) * 1994-09-30 2002-06-04 ファイザー・インク 2,7−置換オクタヒドロ−1h−ピリド[1,2−a]ピラジン誘導体
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
PL378749A1 (pl) * 2003-03-12 2006-05-15 Pfizer Products Inc. Azabicykliczne pochodne pirydyloksymetylowe i benzoizoksazolowe
EP2919788A4 (de) 2012-11-14 2016-05-25 Univ Johns Hopkins Verfahren und zusammensetzungen zur behandlung von schizophrenie
CN104918938B (zh) * 2012-12-20 2017-08-15 詹森药业有限公司 新颖的作为γ分泌酶调节剂的三环3,4‑二氢‑2H‑吡啶并[1,2‑a]吡嗪‑1,6‑二酮衍生物
EP2945944B1 (de) 2013-01-17 2016-11-09 Janssen Pharmaceutica, N.V. Neuartige substituierte pyrido-piperazinon-derivate als gamma-sekretase-modulatoren
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
CN1071167A (zh) 1993-04-21
DK0607163T3 (da) 1997-03-17
IL103204A (en) 1996-05-14
HU9400851D0 (en) 1994-06-28
EP0607163A1 (de) 1994-07-27
FI941377A (fi) 1994-03-24
EP0607163B1 (de) 1996-12-11
NO941084L (no) 1994-03-24
IL103204A0 (en) 1993-02-21
GR3022483T3 (en) 1997-05-31
CZ395792A3 (en) 1994-05-18
NZ244473A (en) 1995-04-27
CA2118936A1 (en) 1993-04-01
JPH08827B2 (ja) 1996-01-10
HUT71488A (en) 1995-11-28
AU2460992A (en) 1993-04-27
MY108303A (en) 1996-09-30
TW215090B (de) 1993-10-21
MX9205385A (es) 1993-03-01
BR9206541A (pt) 1995-04-25
JPH06506701A (ja) 1994-07-28
PL170889B1 (pl) 1997-02-28
US5565453A (en) 1996-10-15
WO1993006101A1 (en) 1993-04-01
DE69215886T2 (de) 1997-04-03
NO941084D0 (no) 1994-03-24
ES2096099T3 (es) 1997-03-01
AU655071B2 (en) 1994-12-01
CZ281775B6 (cs) 1997-01-15
FI941377A0 (fi) 1994-03-24
PT100891A (pt) 1993-10-29
ATE146178T1 (de) 1996-12-15
DE69215886D1 (de) 1997-01-23

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
IL99676A0 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines,and compositions and methods of use thereof
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
NZ239921A (en) Substituted xanthine derivatives; medicaments.
HK1011971A1 (en) Quinoxalines, process for their preparation and their use
EP0781561A4 (de) Eine neuartige medizinische verwendung eines 5ht 3?-antagonisten
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
ZA927306B (en) Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines
MY132057A (en) Quinoxalinones, a process for their preparation and their use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
ZA977057B (en) 1,4-dihydropyridine compounds.
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
ATE138662T1 (de) Antibiotische 7-aminonaphthazarinderivate
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
EP0509098A4 (en) Ataractic
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
GR3015592T3 (en) Pharmaceuticals containing substituted cyclohex-2-en-1-yl-amine derivatives and their use in combatting diseases.
FI990433A0 (fi) Neuroleptisiä perhydro-1H-pyrido(1,2-a)pyratsiineja
GB9022046D0 (en) New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
ES1018974Y (es) "cenicero perfeccionado".
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler
ITOR910001A0 (it) Pate' di muggine affumicato.